BioAffinity Technologies stockBIAF
BioAffinity Technologies trades at $2.60, 87.2% below its 52-week high (Sep 4, 2026). The price is below its 50- and 200-day averages, a downtrend. +120.3% year to date, +19.8% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 18, 2026.
Ratings, candles, signals and the screener for BIAF — after you log in
Open the terminalFrequently asked questions about BioAffinity Technologies
What is the BioAffinity Technologies stock price?
At the close on Nov 5, 2026: $2.60 (−11.26% on the day). 52-week high: $20.35 on Sep 4, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does BioAffinity Technologies report earnings?
The next quarterly report is on Nov 18, 2026. Last quarter, earnings per share changed +87% year over year, revenue +19%.
Does BioAffinity Technologies pay dividends?
No, BioAffinity Technologies does not pay dividends.
Where does BioAffinity Technologies trade and how to buy it?
Ticker BIAF, exchange Nasdaq, listed since 2022. You can buy it through a broker with access to US exchanges.
Should I buy BioAffinity Technologies now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for BIAF are in the terminal after you log in.